Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Roche Basel Switzerland

Roche’s investigational drug first to show efficacy in MS

Ocrelizumab shows positive results in large phase III study

- PMLiVE

Novartis’ Cosentyx effective in psoriatic arthritis study

Further supports drugs ability to reduce progression of damage to joints

Roche's Perjeta pertuzumab

Roche’s Perjeta launches in UK for early breast cancer

Says nearly 2,000 women each year could benefit from its drug

- PMLiVE

Novo Nordisk appoints new senior principal clinical scientist

Stephen Gough joins the Danish diabetes giant

- PMLiVE

EMD Serono appoints new US chief medical officer

Joseph Leveque to enhance firm’s clinical presence in the US

- PMLiVE

New behavioural science comms consultancy launches

In the Wild will be led by managing director Andrew Martello

- PMLiVE

Dr Maurice Chagnaud appointed as new CEO of Polpharma

Will take the reins at the Polish pharmaceutical group week

EU flag

CHMP recommends 19 new medicines for European approval

Praxbind and Entresto - both fast-tracked - among those to be backed

- PMLiVE

Bayer restructures its operations, drops Bayer Healthcare group

Will instead have divisions for pharmaceuticals, consumer health and crop science

Sanofi reception

Sanofi’s lixisenatide is back under FDA review

Brings GLP-1 agonist closer to US market

Eli Lilly HQ

Third positive phase III trial for Lilly/Incyte’s baricitinib

Baricitinib beats methotrexate in rheumatoid arthritis

Bigger than brand: Portfolio Positioning for Pharma

Senior Consultant Jenna Earl talks us through the three most important things to understand about portfolio positioning in pharma.

Blue Latitude Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links